Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hai-guang Xin"'
Autor:
Xin, Zeng, Xia, Sheng, Pei-Qin, Wang, Hai-Guang, Xin, Yi-Bin, Guo, Yong, Lin, Jia-Wei, Zhong, Cheng-Zhi, He, Jie, Yin, Tao-Tao, Liu, Wei-Juan, Ma, Xiao, Xiao, Pei-Mei, Shi, Zong-Li, Yuan, Ling, Yang, Xiong, Ma, Jian-Ming, Xu, Xi-Zhong, Shen, Chang-Qing, Yang, Xuan, Zhu, Nong-Hua, Lv, Wei-Fen, Xie
Publikováno v:
Hepatology international. 15(1)
Rifaximin has been recommended as a prophylactic drug for hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP). This study aims to explore whether low-dose rifaximin can prevent overall complications and prolong survival in cirrhot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::763ccfb7c381d3739a309e589ef27e0f
https://pubmed.ncbi.nlm.nih.gov/33385299
https://pubmed.ncbi.nlm.nih.gov/33385299
Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study
Autor:
Xia Jiao Tang, Zong Li Yuan, Yong Lin, Bin Shi, Hai Guang Xin, Wu Ni, Wei Fen Xie, Wei Zhong Chen, Xin Zeng, Yue Xiang Chen, Xia Sheng, Jian Shi, Cai Feng Jiang
Publikováno v:
Journal of Digestive Diseases. 16:665-674
Objective To evaluate the efficacy, safety and tolerability of different doses of rifaximin in Chinese patients with liver cirrhosis. Methods This random prospective study included a screening visit, a 2-week treatment period and a subsequent 4-week
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::468d11d8b6042fce1ac0738ba4ef9ebb
https://doi.org/10.1111/1751-2980.12294
https://doi.org/10.1111/1751-2980.12294
Publikováno v:
European journal of clinical pharmacology. 67(6)
High-grade bleeding is a serious adverse event associated with bevacizumab, a humanized monoclonal antibody targeting vascular endothelial growth factor and widely used in the current cancer treatments. The aim of this study was to gain a better unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc0ebbcc093990002ee2ce06f78166d
https://pubmed.ncbi.nlm.nih.gov/21243343
https://pubmed.ncbi.nlm.nih.gov/21243343
Autor:
Hai-guang Xin, Chang-xing Guo, Jing-xi Zhang, Cheng-zhong Li, Yi Liu, Zhi-qing He, Zhi-hui Chen
Publikováno v:
Academic Journal of Second Military Medical University. 36:602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cf32509551877d2c46dcc2641f1d75d
https://doi.org/10.3724/sp.j.1008.2015.00602
https://doi.org/10.3724/sp.j.1008.2015.00602
Autor:
Jin-tao Ju, Chang-xing Guo, Ye Lu, Cheng-zhong Li, Xiao-ping Shao, Chang-li Wan, Hai-guang Xin, Zhi-qing He, Jing Chen, Wu Yang
Publikováno v:
Academic Journal of Second Military Medical University. 36:813
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc309f634a01db2685c72bb2d58d089c
https://doi.org/10.3724/sp.j.1008.2015.00813
https://doi.org/10.3724/sp.j.1008.2015.00813
Autor:
Hai-Guang Xin1, Bei-Bei Zhang1, Zhi-Qin Wu1, Xiao-Feng Hang1, Wen-Sheng Xu1, Wu Ni1, Rui-Qi Zhang1, Xiao-Hui Miao1 miaoxh2013@hotmail.com
Publikováno v:
European Journal of Pharmacology. Sep2014, Vol. 738, p310-318. 9p.